Sales rise 106.67% to Rs 0.62 crore
Net loss of Rubra Medicaments reported to Rs 0.02 crore in the quarter ended March 2022. There were no net profit/loss reported during the previous quarter ended March 2021. Sales rose 106.67% to Rs 0.62 crore in the quarter ended March 2022 as against Rs 0.30 crore during the previous quarter ended March 2021.For the full year,net loss reported to Rs 0.04 crore in the year ended March 2022 as against net profit of Rs 0.01 crore during the previous year ended March 2021. Sales rose 310.20% to Rs 2.01 crore in the year ended March 2022 as against Rs 0.49 crore during the previous year ended March 2021.
ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales0.620.30 107 2.010.49 310 OPM %-1.610 --1.492.04 - PBDT-0.010 0 -0.030.01 PL PBT-0.010 0 -0.030.01 PL NP-0.020 0 -0.040.01 PL
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
